Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Arthritis, Rheumatoid

fluorobenzenes has been researched along with Arthritis, Rheumatoid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammer, HB; Hisdal, J; Holme, I; Ikdahl, E; Kitas, GD; Kvien, TK; Olsen, IC; Pedersen, TR; Rollefstad, S; Semb, AG; Smerud, KT1
Freedman, B; Kuan, WP; Lee, KK; Lee, VW; Li, EK; Li, M; Li, TK; Shang, Q; Tam, LS; Tomlinson, B; Tseung, L; Yip, GW; Yu, CM1
Belch, JJ; Kennedy, G; Khan, F; Kumar, P; Pullar, T1
Anderson, JA; Buchanan, WW; Lee, P; Miller, J; Webb, J1

Trials

4 trial(s) available for fluorobenzenes and Arthritis, Rheumatoid

ArticleYear
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
    Arthritis & rheumatology (Hoboken, N.J.), 2015, Volume: 67, Issue:7

    Topics: Acute Coronary Syndrome; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Carotid Stenosis; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Spondylitis, Ankylosing; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional

2015
Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
    Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:6

    Topics: Apolipoproteins B; Arthritis, Rheumatoid; Atherosclerosis; Carotid Intima-Media Thickness; Carotid Stenosis; Cholesterol; Disease Progression; Double-Blind Method; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Treatment Outcome; Vascular Stiffness

2011
Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.
    Scottish medical journal, 2012, Volume: 57, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disease Progression; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Scotland; Sulfonamides; Treatment Outcome

2012
[Comparative evaluation of the therapeutic efficiency of flurbiprofene in rheumatoid polyarthritis].
    Revue du rhumatisme et des maladies osteo-articulaires, 1975, Volume: 42, Issue:6

    Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Biphenyl Compounds; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Fluorobenzenes; Flurbiprofen; Humans; Indomethacin; Mefenamic Acid; Pain; Phenylpropionates; Placebos; Prednisone; Propionates

1975